Wedbush Securities’s Amgen AMGN Stock Holding History

Wedbush Securities’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.9M	Buy	30,997 +1,212	+4%	+$432K	0.32%	47
2025 Q4	$9.75M	Buy	29,785 +1,322	+5%	+$419K	0.28%	50
2025 Q3	$8.03M	Buy	28,463 +1,557	+6%	+$452K	0.26%	49
2025 Q2	$7.51M	Sell	26,906 -3,536	-12%	-$1M	0.26%	53
2025 Q1	$9.48M	Sell	30,442 -2,583	-8%	-$763K	0.35%	42
2024 Q4	$8.61M	Buy	33,025 +467	+1%	+$139K	0.31%	46
2024 Q3	$10.5M	Sell	32,558 -2,771	-8%	-$906K	0.39%	35
2024 Q2	$11M	Buy	35,329 +860	+2%	+$253K	0.39%	32
2024 Q1	$9.8M	Buy	34,469 +2,857	+9%	+$836K	0.37%	42
2023 Q4	$9.11M	Buy	31,612 +35	+0.1%	+$9.54K	0.4%	40
2023 Q3	$8.49M	Buy	31,577 +870	+3%	+$217K	0.42%	35
2023 Q2	$6.82M	Sell	30,707 -2,765	-8%	-$642K	0.33%	51
2023 Q1	$8.09M	Buy	33,472 +4,127	+14%	+$1.01M	0.4%	32
2022 Q4	$7.71M	Sell	29,345 -1,536	-5%	-$412K	0.42%	35
2022 Q3	$6.96M	Buy	30,881 +4,698	+18%	+$1.14M	0.39%	38
2022 Q2	$6.37M	Sell	26,183 -121	-0.5%	-$29.7K	0.35%	49
2022 Q1	$6.36M	Buy	26,304 +38	+0.1%	+$8.73K	0.29%	52
2021 Q4	$5.91M	Buy	26,266 +1,631	+7%	+$344K	0.25%	60
2021 Q3	$5.24M	Sell	24,635 -192	-0.8%	-$44.2K	0.25%	60
2021 Q2	$6.05M	Buy	24,827 +7,297	+42%	+$1.8M	0.29%	54
2021 Q1	$4.36M	Buy	17,530 +2,835	+19%	+$676K	0.24%	59
2020 Q4	$3.38M	Buy	14,695 +978	+7%	+$225K	0.3%	67
2020 Q3	$3.49M	Sell	13,717 -3,689	-21%	-$914K	0.33%	56
2020 Q2	$4.11M	Sell	17,406 -265	-1%	-$60.5K	0.39%	50
2020 Q1	$3.58M	Buy	17,671 +238	+1%	+$52K	0.43%	44
2019 Q4	$4.2M	Buy	17,433 +58	+0.3%	+$12.8K	0.37%	50
2019 Q3	$3.36M	Buy	17,375 +617	+4%	+$118K	0.33%	59
2019 Q2	$3.09M	Buy	16,758 +64	+0.4%	+$11.5K	0.31%	62
2019 Q1	$3.17M	Sell	16,694 -3,486	-17%	-$666K	0.34%	52
2018 Q4	$3.93M	Sell	20,180 -1,449	-7%	-$283K	0.5%	33
2018 Q3	$4.48M	Buy	21,629 +1,470	+7%	+$290K	0.51%	31
2018 Q2	$3.72M	Sell	20,159 -1,174	-6%	-$208K	0.46%	38
2018 Q1	$3.64M	Sell	21,333 -1,092	-5%	-$200K	0.48%	34
2017 Q4	$3.9M	Buy	22,425 +764	+4%	+$135K	0.48%	35
2017 Q3	$4.04M	Buy	21,661 +103	+0.5%	+$18.3K	0.52%	36
2017 Q2	$3.71M	Buy	21,558 +191	+0.9%	+$31.1K	0.48%	35
2017 Q1	$3.51M	Buy	21,367 +835	+4%	+$139K	0.48%	35
2016 Q4	$3M	Buy	20,532 +8,630	+73%	+$1.3M	0.44%	38
2016 Q3	$1.99M	Buy	11,902 +1,488	+14%	+$252K	0.3%	63
2016 Q2	$1.58M	Buy	10,414 +1,015	+11%	+$158K	0.26%	76
2016 Q1	$1.41M	Buy	9,399 +1,450	+18%	+$215K	0.24%	85
2015 Q4	$1.29M	Sell	7,949 -277	-3%	-$43.5K	0.23%	93
2015 Q3	$1.14M	Buy	8,226 +232	+3%	+$36.6K	0.23%	99
2015 Q2	$1.23M	Buy	7,994 +298	+4%	+$47.7K	0.23%	93
2015 Q1	$1.23M	Sell	7,696 -994	-11%	-$157K	0.21%	101
2014 Q4	$1.38M	Sell	8,690 -2,677	-24%	-$417K	0.21%	100
2014 Q3	$1.6M	Sell	11,367 -1,686	-13%	-$220K	0.25%	83
2014 Q2	$1.54M	Sell	13,053 -64	-0.5%	-$7.41K	0.25%	88
2014 Q1	$1.62M	Buy	13,117 +5,065	+63%	+$614K	0.28%	82
2013 Q4	$919K	Sell	8,052 -373	-4%	-$42.4K	0.22%	116
2013 Q3	$943K	Buy	8,425 +158	+2%	+$17.1K	0.25%	102
2013 Q2	$816K	Buy	+8,267	New	+$858K	0.22%	113

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wedbush Securities's AMGN Position: Q1 2026 in Review

Wedbush Securities increased its Amgen (AMGN) stake by 4.1% in Q1 2026, buying an estimated $432K and bringing the position to 30,997 shares worth $10.9M. The position accounts for 0.32% of the portfolio, ranked #47.

Wedbush Securities first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $11M in Q2 2024. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Wedbush Securities held 30,997 shares of Amgen worth $10.9M as of Q1 2026.
Wedbush Securities bought 1,212 Amgen shares in Q1 2026, an estimated $432K.
Amgen made up 0.32% of Wedbush Securities's portfolio in Q1 2026, its #47 holding.
Wedbush Securities first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
Wedbush Securities's Amgen position peaked at $11M in Q2 2024.
3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Wedbush Securities's 13F filing for Q1 2026, filed 21 Apr 2026.